Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients
Aims: To carry out an immunohistochemical study on bone marrow (BM) biopsy specimens in 75 patients with chronic myelogenous leukaemia (CML) on long‐term STI571 therapy. Methods and results: Sequential BM specimens taken at intervals of 21 ± 6 months were investigated by enzyme‐ and immunohistoche...
Saved in:
Published in | Histopathology Vol. 46; no. 5; pp. 540 - 550 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.05.2005
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aims: To carry out an immunohistochemical study on bone marrow (BM) biopsy specimens in 75 patients with chronic myelogenous leukaemia (CML) on long‐term STI571 therapy.
Methods and results: Sequential BM specimens taken at intervals of 21 ± 6 months were investigated by enzyme‐ and immunohistochemistry including proliferating cell nuclear antigen and apoptosis. Evaluation was performed either by semiquantitative scoring or by morphometry (CD61+ megakaryopoiesis). In 41 patients with chronic phase CML, treatment resulted in a significant decrease in cellularity and neutrophil granulopoiesis contrasting with an accumulation of erythroid precursor cells. Morphometry showed a reduction of abnormal micromegakaryocytes consistent with normalization. Regression of myelofibrosis was identified in eight of 15 patients, whereas progression occurred in 17 patients; mostly in those with acceleration and blastic crisis. The increased post‐treatment incidence of reactive lymphoid nodules was remarkable. Myeloblasts, CD34+ progenitors and immature myelomonocytic cells initially decreased, but recurred in 14 patients who later developed a relapse. STI571 exerted an inhibitory effect on cell proliferation associated with enhanced apoptosis in responding patients.
Conclusion: Long‐term treatment with STI571 exerts pronounced changes on BM histopathology that not only involve haematopoiesis and stromal constituents, but also proliferation and apoptosis. |
---|---|
Bibliography: | ArticleID:HIS2119 istex:850A58086EA50B014969D2EBBFFB44F61634DD72 ark:/67375/WNG-H96RX8JD-P ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0309-0167 1365-2559 |
DOI: | 10.1111/j.1365-2559.2005.02119.x |